Last week, we reported on an emerging trend in the European medical cannabis industry, which is seeing regulators in incoming
As Europe’s medical cannabis market shifts from a focus on growth to pharmaceutical discipline, PHCANN International has emerged as a
In the latest instalment of our series spotlighting the expert contributors to Prohibition Partners’ newly launched Insights Hub, we sat
Last month, Slovenia’s parliament passed a law to significantly open up access to medical cannabis, coinciding with the presentation of
Its unique position will set GROW apart from other players in the European market.
We won’t spam you
